-
July 25, 2022 Exploring the History and Therapeutic Potential of AyahuascaResearchers are exploring the therapeutic potential of ayahuasca, a visionary brew containing DMT. Here's everything...
-
July 22, 2022 A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 TrialCompass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new...
-
July 22, 2022 Company Spotlight: NaturoMed TherapeuticsCanadian organic mushroom company NaturoMed Therapeutics looks to produce psilocybin in Q4 2022
-
July 21, 2022 Opiate Addiction: Jails, Institutions, Death… and PsychedelicsPsychedelics have the potential to treat the suffering caused by opiate addiction, but treatment is...
-
July 20, 2022 6 Underrated Music-Filled Movies to Watch While You TripOut of ideas for what to stream tonight? Take a chance on some of these...
-
July 19, 2022 Compass Pathways Appoints a New CEOGeorge Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?
-
July 19, 2022 Canada Halts MDMA Clinical Trial Over Concerns for Participant SafetyDeficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in...
-
July 18, 2022 The Sloppy Science of Psilocybin Microdosing SurveysMany researchers are rushing to validate the efficacy of psilocybin microdosing for a variety of...
-
July 15, 2022 The Health Benefits of taking Mushroom SupplementsMushroom supplements can provide a natural way to boost mood, lower stress, and improve sleep....
-
July 14, 2022 How to Change Your Mind Review: The Psychedelic Hype Train Keeps ChuggingThe Netflix documentary 'How to Change Your Mind' is great TV even though it fails...
